NCT03082560

Brief Summary

The study's Primary Objective is to design and validate a grading system for objective and accurate assessment of lichen planopilaris. Secondary Objectives:

  • To assess change in symptoms such as pain and itch using a Numeric Rating Scale(NRS) scores and quality of life using the Dermatology Life Quality Index (DLQI) scores
  • To correlate this grading system with patient skin biopsies evaluating disease activity on a microscopic level
  • To correlate this grading system with digital global photography and trichoscopy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 13, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 17, 2017

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2020

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

January 26, 2022

Status Verified

January 1, 2022

Enrollment Period

3.6 years

First QC Date

March 13, 2017

Last Update Submit

January 24, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)

    Design and validate a grading system for objective and accurate assessment of lichen planopilaris.

    6 months

Study Arms (1)

Group 1

Healthy adult patients with lichen planopilaris

Diagnostic Test: Boston Grade of Activity in Lichen Planopilaris

Interventions

A clinical assessment tool to objectively and accurately measure activity and severity in lichen planopilaris over time.

Group 1

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy adult subjects with lichen planopilaris

You may qualify if:

  • Male or female subjects in general good health between the ages of 18 and 80 years old
  • Clinical and histologic diagnosis of lichen planopilaris
  • Subject is able to understand and sign informed consent
  • Subject is able to complete the study and comply with study procedures
  • Subject has no known allergy to non-toxic ink
  • Subjects should be managed by an Massachusetts General Hospital dermatologist for their lichen planopilaris for the duration of the study

You may not qualify if:

  • Eligible subjects will be excluded from participation if they meet any of the following criteria:
  • Presence of dermatoses that might interfere with LPP diagnosis and/or evaluation such as seborrheic dermatitis or psoriasis
  • Other selected concomitant causes of hair loss, including discoid lupus erythematosus, central centrifugal cicatricial alopecia (CCCA), telogen effluvium
  • Abnormal TSH laboratory value \>1 standard deviation above normal within last year
  • Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment
  • Any known allergy to non-toxic ink Related to Biopsy
  • History of poor wound healing or blood-clotting abnormality
  • History of keloid formation or hypertrophic scarring
  • Regular intake of high doses of aspirin or anti-coagulant medications
  • Hypersensitivity to local anesthetics
  • History of poorly controlled diabetes mellitus
  • Pregnant, nursing or planning a pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Lichen Planus

Condition Hierarchy (Ancestors)

Lichenoid EruptionsSkin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Maryanne Senna, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dermatologist

Study Record Dates

First Submitted

March 13, 2017

First Posted

March 17, 2017

Study Start

February 10, 2017

Primary Completion

September 11, 2020

Study Completion

December 1, 2022

Last Updated

January 26, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations